These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 11884485

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.
    Chen SJ, Wang YL, Lo WT, Wu CC, Hsieh CW, Huang CF, Lan YH, Wang CC, Chang DM, Sytwu HK.
    Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis.
    Williams JL, Kithcart AP, Smith KM, Shawler T, Cox GM, Whitacre CC.
    J Neuroimmunol; 2011 May; 234(1-2):84-92. PubMed ID: 21463904
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S, Senju S, Matsuyoshi H, Fukuma D, Uemura Y, Nishimura Y.
    J Immunol; 2005 Feb 15; 174(4):1888-97. PubMed ID: 15699115
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. CD43 modulates severity and onset of experimental autoimmune encephalomyelitis.
    Ford ML, Onami TM, Sperling AI, Ahmed R, Evavold BD.
    J Immunol; 2003 Dec 15; 171(12):6527-33. PubMed ID: 14662853
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.
    Chang TT, Jabs C, Sobel RA, Kuchroo VK, Sharpe AH.
    J Exp Med; 1999 Sep 06; 190(5):733-40. PubMed ID: 10477557
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S.
    J Neuroimmunol; 2002 Apr 06; 125(1-2):114-24. PubMed ID: 11960647
    [Abstract] [Full Text] [Related]

  • 35. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
    Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.
    Immunology; 2009 Sep 06; 128(1 Suppl):e250-61. PubMed ID: 19175799
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
    Reiman R, Gerard C, Campbell IL, Barnum SR.
    Eur J Immunol; 2002 Apr 06; 32(4):1157-63. PubMed ID: 11932923
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis.
    Bullard DC, Hu X, Schoeb TR, Axtell RC, Raman C, Barnum SR.
    J Immunol; 2005 Nov 15; 175(10):6327-33. PubMed ID: 16272284
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.